069620 — Daewoong Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩2tn
- KR₩3tn
- KR₩2tn
Annual cashflow statement for Daewoong Pharma, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 30,257 | 39,163 | 120,003 | 23,347 | 192,909 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 13,038 | 27,049 | 16,450 | 122,489 | 15,269 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -42,865 | 13,650 | -43,145 | -142,481 | -109,240 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 39,994 | 118,215 | 136,009 | 51,492 | 149,205 |
| Capital Expenditures | -29,088 | -65,161 | -109,338 | -155,145 | -191,534 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -58,595 | -41,710 | -56,283 | -110,306 | -55,492 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -87,683 | -106,872 | -165,621 | -265,451 | -247,026 |
| Financing Cash Flow Items | 18,740 | 25,050 | 0 | 4,693 | -334 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 50,224 | 15,517 | 39,218 | 200,621 | 164,352 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3,608 | 27,044 | 8,555 | -8,556 | 65,991 |